View in EDS HTML Full Text PDF Full Text

Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes.

Saved in:
Bibliographic Details
Title: Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes.
Authors: Lim CE; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden., Pasternak B; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden.; Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark., Eliasson B; Department of Medicine, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden.; The Swedish National Diabetes Register, Center of Registers, Medicinaregatan 18 G, 413 45 Gothenburg, Sweden., Danaei G; Department of Global Health and Population, Harvard TH Chan School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA., Ueda P; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden.
Source: European journal of preventive cardiology [Eur J Prev Cardiol] 2023 Jun 01; Vol. 30 (8), pp. 634-643.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print Cited Medium: Internet ISSN: 2047-4881 (Electronic) Linking ISSN: 20474873 NLM ISO Abbreviation: Eur J Prev Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36582120
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lim+CE%22">Lim CE</searchLink>; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Pasternak+B%22">Pasternak B</searchLink>; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden.; Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Eliasson+B%22">Eliasson B</searchLink>; Department of Medicine, Sahlgrenska University Hospital, Blå stråket 5, 413 45 Gothenburg, Sweden.; The Swedish National Diabetes Register, Center of Registers, Medicinaregatan 18 G, 413 45 Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Danaei+G%22">Danaei G</searchLink>; Department of Global Health and Population, Harvard TH Chan School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Ueda+P%22">Ueda P</searchLink>; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Maria Aspmans Gata 16, 17176 Stockholm, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101564430%22">European journal of preventive cardiology</searchLink> [Eur J Prev Cardiol] 2023 Jun 01; Vol. 30 (8), pp. 634-643.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101564430 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2047-4881 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220474873%22">20474873 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Prev Cardiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36582120
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/eurjpc/zwac315
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 634
    Titles:
      – TitleFull: Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lim CE
      – PersonEntity:
          Name:
            NameFull: Pasternak B
      – PersonEntity:
          Name:
            NameFull: Eliasson B
      – PersonEntity:
          Name:
            NameFull: Danaei G
      – PersonEntity:
          Name:
            NameFull: Ueda P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2023 Jun 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2047-4881
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: European journal of preventive cardiology
              Type: main
ResultId 1